Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 0 | 146 | 1,597 | 1,598 | 1,597 |
| Gross Profit | N/A | 146 | 1,597 | 1,598 | 1,597 |
| Operating Expenses | 12,378 | 16,342 | 15,033 | 14,676 | 14,611 |
| Operating Income | -12,378 | -16,196 | -13,436 | -13,078 | -13,014 |
| Other Income | 347 | 176 | 163 | 377 | 152 |
| Pre-tax Income | -12,031 | -16,020 | -13,273 | -12,701 | -12,862 |
| Net Income Continuous | -12,031 | -16,020 | -13,273 | -12,701 | -12,862 |
| Net Income | $-12,031 | $-16,020 | $-13,273 | $-12,701 | $-12,862 |
| EPS Basic Total Ops | -17.99 | -22.49 | -17.99 | -19.49 | -19.49 |
| EPS Basic Continuous Ops | -12.79 | -17.05 | -13.95 | -13.54 | -14.22 |
| EPS Diluted Total Ops | -17.99 | -22.49 | -17.99 | -19.49 | -19.49 |
| EPS Diluted Continuous Ops | -12.79 | -17.05 | -13.95 | -13.54 | -14.22 |
| EBITDA(a) | $-12,240 | $-16,079 | $-13,326 | $-12,986 | $-12,926 |